nach oben

European Radiology

Erschienen in:

01.07.2011 | Breast

Normal parenchymal enhancement patterns in women undergoing MR screening of the breast

verfasst von: Sanaz A. Jansen, Vicky C. Lin, Maryellen L. Giger, Hui Li, Gregory S. Karczmar, Gillian M. Newstead

Erschienen in: European Radiology | Ausgabe 7/2011

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To characterize the kinetic and morphological presentation of normal breast tissue on DCE-MRI in a large cohort of asymptomatic women, and to relate these characteristics to breast tissue density.

Methods

335 consecutive breast MR examinations in 229 asymptomatic women undergoing high-risk screening evaluations based on recommendations from the American Cancer Society including strong family history and genetic predisposition were selected for IRB-approved review (average age 49.2 ± 10.5 years). Breast tissue density was assessed on precontrast T₂-weighted images. Parenchymal enhancement pattern (PEP) was qualitatively classified as minimal, homogeneous, heterogeneous or nodular. Quantitative analysis of parenchymal enhancement kinetics (PEK) was performed, including calculation of initial and peak enhancement percentages (E ₁, E _peak), the time to peak enhancement (T _peak) and the signal enhancement ratio (SER).

Results

41.8% of examinations were classified as minimal, 13.7% homogeneous, 23.9% heterogeneous and 21.2% nodular PEP. Women with heterogeneously or extremely dense breasts exhibited a higher proportion of nodular PEP (44.2% (27/61)) and significantly higher E ₁, and E _peak (p < 0.003) compared with those with less dense breasts.

Conclusions

Qualitative and quantitative parenchymal enhancement characteristics vary by breast tissue density. In future work, the association between image-derived MR features of the normal breast and breast cancer risk should be explored.

Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D (2008) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148:671–679PubMed

Molleran V, Mahoney MC (2010) The BI-RADS breast magnetic resonance imaging lexicon. Magn Reson Imaging Clin N Am 18:171–185. doi:10.1016/j.mric.2010.02.001, viiPubMedCrossRef

Kuhl CK, Bieling HB, Gieseke J et al (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203:137–144PubMed

Pfleiderer SO, Sachse S, Sauner D et al (2004) Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res 6:R232–R238. doi:10.1186/bcr779 PubMedCrossRef

Liu F, Peacock S, DeMartini W, Eby P, Lehman CD (2008) Background parenchymal enhancement on BREAST MRI: characterization and impact on diagnostic accuracy(ed)^(eds). Radiological Society of North America, Chicago

Li H, Giger ML, Jansen SA, Lan L, Bhooshan N, Newstead GM (2009) Computerized breast parenchymal analysis on DCE-MRI.(ed)^(eds) SPIE Medical Imaging Conference

Boyd NF, Martin LJ, Yaffe MJ, Minkin S (2006) Mammographic density: a hormonally responsive risk factor for breast cancer. J Br Menopause Soc 12:186–193. doi:10.1258/136218006779160436 PubMedCrossRef

Boyd N, Martin L, Gunasekara A et al (2009) Mammographic density and breast cancer risk: evaluation of a novel method of measuring breast tissue volumes. Cancer Epidemiol Biomark Prev 18:1754–1762. doi:10.1158/1055-9965.EPI-09-0107 CrossRef

Boyd NF, Martin LJ, Bronskill M, Yaffe MJ, Duric N, Minkin S (2010) Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst. doi:10.1093/jnci/djq239

10.

Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Garrido L (2005) Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue. Breast J 11(4):236–241. doi:10.1111/j.1075-122X.2005.21499.x PubMedCrossRef

11.

Muller-Schimpfle M, Ohmenhauser K, Stoll P, Dietz K, Claussen CD (1997) Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 203:145–149PubMed

12.

Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354:270–282. doi:10.1056/NEJMra050776 PubMedCrossRef

13.

Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75–89PubMedCrossRef

14.

Jansen SA, Shimauchi A, Zak L et al (2009) Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition. AJR Am J Roentgenol 193(3):832–839. doi:10.2214/AJR.08.2025 PubMedCrossRef

15.

Esserman L, Hylton N, George T, Weidner N (1999) Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J 5:13–21PubMedCrossRef

16.

Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Statist 6:65–70

17.

Jansen SA, Newstead GM, Abe H, Shimauchi A, Schmidt RA, Karczmar GS (2007) Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology 245:684–691. doi:10.1148/radiol.2453062061 PubMedCrossRef

18.

Heywang-Kobrunner SH, Schlegel A, Beck R et al (1993) Contrast-enhanced MRI of the breast after limited surgery and radiation therapy. J Comput Assist Tomogr 17:891–900PubMedCrossRef

19.

Wersebe A, Xydeas T, Clauss T et al (2001) Quantitative assessment of therapy related effects after breast conserving therapy with dynamic MRI of the breast. Rofo 173:1109–1117. doi:10.1055/s-2001-18887 PubMed

20.

Boston RC, Schnall MD, Englander SA, Landis JR, Moate PJ (2005) Estimation of the content of fat and parenchyma in breast tissue using MRI T1 histograms and phantoms. Magn Reson Imaging 23:591–599. doi:10.1016/j.mri.2005.02.006 PubMedCrossRef

21.

Nie K, Chang D, Chen JH, Hsu CC, Nalcioglu O, Su MY (2010) Quantitative analysis of breast parenchymal patterns using 3D fibroglandular tissues segmented based on MRI. Med Phys 37:217–226PubMedCrossRef

22.

Lorenzen J, Sinkus R, Biesterfeldt M, Adam G (2003) Menstrual-cycle dependence of breast parenchyma elasticity: estimation with magnetic resonance elastography of breast tissue during the menstrual cycle. Invest Radiol 38:236–240. doi:10.1097/01.RLI.0000059544.18910.BD PubMed

23.

Partridge SC, McKinnon GC, Henry RG, Hylton NM (2001) Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI. J Magn Reson Imaging 14:433–438. doi:10.1002/jmri.1204 PubMedCrossRef

24.

Partridge SC, Murthy RS, Ziadloo A, White SW, Allison KH, Lehman CD (2010) Diffusion tensor magnetic resonance imaging of the normal breast. Magn Reson Imaging 28(3):320–328. doi:10.1016/j.mri.2009.10.003 PubMedCrossRef

25.

Hattangadi J, Park C, Rembert J et al (2008) Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy. AJR Am J Roentgenol 190:1630–1636. doi:10.2214/AJR.07.2533 PubMedCrossRef

26.

Kuhl C (2007) The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 244:356–378. doi:10.1148/radiol.2442051620 PubMedCrossRef

27.

Cubuk R, Tasali N, Narin B, Keskiner F, Celik L, Guney S (2010) Correlation between breast density in mammography and background enhancement in MR mammography. Radiol Med 115:434–441. doi:10.1007/s11547-010-0513-4 PubMedCrossRef

28.

Ko ES, Lee BH, Choi HY, Kim RB, Noh WC (2010) Background enhancement in breast MR: correlation with breast density in mammography and background echotexture in ultrasound. Eur J Radiol. doi:10.1016/j.ejrad.2010.07.019

29.

Passaperuma K, Warner E, Hill KA, Gunasekara A, Yaffe MJ (2010) Is mammographic breast density a breast cancer risk factor in women with BRCA mutations? J Clin Oncol. doi:10.1200/JCO.2009.27.5933 PubMed

30.

Boyd N, Martin L, Chavez S et al (2009) Breast-tissue composition and other risk factors for breast cancer in young women: a cross-sectional study. Lancet Oncol 10:569–580. doi:10.1016/S1470-2045(09)70078-6 PubMedCrossRef

31.

Khazen M, Warren RM, Boggis CR et al (2008) A pilot study of compositional analysis of the breast and estimation of breast mammographic density using three-dimensional T1-weighted magnetic resonance imaging. Cancer Epidemiol Biomark Prev 17:2268–2274. doi:10.1158/1055-9965.EPI-07-2547 CrossRef

32.

Lee NA, Rusinek H, Weinreb J et al (1997) Fatty and fibroglandular tissue volumes in the breasts of women 20–83 years old: comparison of X-ray mammography and computer-assisted MR imaging. AJR Am J Roentgenol 168:501–506PubMed

33.

Thompson DJ, Leach MO, Kwan-Lim G et al (2009) Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study. Breast Cancer Res 11(6):R80. doi:10.1186/bcr2447 PubMedCrossRef

34.

Chen W, Giger ML, Bick U, Newstead GM (2006) Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI. Med Phys 33:2878–2887PubMedCrossRef

35.

Collins MJ, Hoffmeister J, Worrell SW (2006) Computer-aided detection and diagnosis of breast cancer. Semin Ultrasound CT MR 27:351–355PubMedCrossRef

36.

Hologic (2010) Hologic-Quantra Volumetric Assessment. http://www.hologic.com/en/breast-screening/volumetric-assessment/. Accessed January 31, 2011

37.

Huo Z, Giger ML, Olopade OI et al (2002) Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers. Radiology 225:519–526PubMedCrossRef

38.

Li H, Giger ML, Olopade OI, Margolis A, Lan L, Chinander MR (2005) Computerized texture analysis of mammographic parenchymal patterns of digitized mammograms. Acad Radiol 12:863–873. doi:10.1016/j.acra.2005.03.069 PubMedCrossRef

39.

Jansen SA, Paunesku T, Fan X et al (2009) Ductal carcinoma in situ: x-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine model. Radiology 253(2):399–406. doi:10.1148/radiol.2533082026 PubMedCrossRef

40.

Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Halpern EF, Garrido L (2005) Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging–initial observations. Radiology 235:36–41. doi:10.1148/radiol.2351040012 PubMedCrossRef

41.

Heinig A, Lampe D, Kolbl H, Beck R, Heywang-Kobrunner SH (2002) Suppression of unspecific enhancement on breast magnetic resonance imaging (MRI) by antiestrogen medication. Tumori 88:215–223PubMed

42.

Lorenzen J, Welger J, Lisboa BW, Krupski G, Adam G (2003) MR-imaging of the breast at 0.5 Tesla: menstrual-cycle dependency of parenchymal contrast enhancement in healthy volunteers with oral contraceptive use? Rofo 175:502–506. doi:10.1055/s-2003-38449 PubMed

43.

Reichenbach JR, Przetak C, Klinger G, Kaiser WA (1999) Assessment of breast tissue changes on hormonal replacement therapy using MRI: a pilot study. J Comput Assist Tomogr 23:407–413PubMedCrossRef

44.

Abitbol CL, Warady BA, Massie MD et al (1990) Linear growth and anthropometric and nutritional measurements in children with mild to moderate renal insufficiency: a report of the Growth Failure in Children with Renal Diseases Study. J Pediatr 116:S46–S54PubMedCrossRef

Titel: Normal parenchymal enhancement patterns in women undergoing MR screening of the breast
verfasst von: Sanaz A. Jansen
Vicky C. Lin
Maryellen L. Giger
Hui Li
Gregory S. Karczmar
Gillian M. Newstead
Publikationsdatum: 01.07.2011
Verlag: Springer-Verlag
Erschienen in: European Radiology / Ausgabe 7/2011
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-011-2080-z

Neu im Fachgebiet Radiologie

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Normal parenchymal enhancement patterns in women undergoing MR screening of the breast

Abstract

Objectives

Methods

Results

Conclusions

Neu im Fachgebiet Radiologie

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Quantitative Angiografie könnte IVUS-Alternative darstellen

Update Radiologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2011

CT of the hips in the investigation of protrusio acetabuli in Marfan syndrome. A case control study

Early postoperative MRI overestimates residual tumour after resection of gliomas with no or minimal enhancement

High diagnostic accuracy of prospective ECG-gating 64-slice computed tomography coronary angiography for the detection of in-stent restenosis

Erratum to: Fibromatosis of the breast in a 52-year-old man (2010: 10b)

Feasibility of dynamic MRI for evaluating velopharyngeal insufficiency in children

Feasibility of simultaneous PET/MR imaging in the head and upper neck area

Neu im Fachgebiet Radiologie

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Quantitative Angiografie könnte IVUS-Alternative darstellen

Update Radiologie